Newsroom
Insights into LOVE
Welcome to our newsroom where we post news, events, and financial updates.
June 2, 2023
JOLT HEALTH INC. ANNOUNCES NEW CEO AND DIRECTOR TO LEAD BIOTECHNOLOGY, HEALTHCARE AND AI INITIATIVES
VANCOUVER, BC, CANADA (June 2nd, 2023) – Jolt Health Inc. (“JOLT” and or “The Company”)(CSE: JOLT) (FSE: G1Q0) (previously Love
Read MoreMay 25, 2023
JOLT Health Inc. Announces Issuance of Common Shares in Satisfaction of Interest Payments to Promissory Note Holders and Interest Payment to Convertible Debenture Holder
VANCOUVER, BC, CANADA (May 25, 2023) – Jolt Health Inc. (formerly Love Pharma Inc.) (“Jolt” and or “the Company”) (CSE:JOLT)
Read MoreMay 16, 2023
LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH INC.” AND INCREASED FOCUS ON BIOTECHNOLOGY
VANCOUVER, BC, CANADA (May 16, 2023) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased
Read MoreApril 5, 2023
LOVE PHARMA TO EVALUATE MINING OPPORTUNITIES
VANCOUVER, BC, CANADA (April 5, 2023) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is currently
Read MoreApril 3, 2023
LOVE PHARM INC. ANNOUNCES GRANT OF STOCK OPTIONS
VANCOUVER, BC, CANADA (April 3, 2023) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased
Read MoreFebruary 27, 2023
LOVE PHARMA INC. ANNOUNCES SHARE CONSOLIDATION
VANCOUVER, BC, CANADA (February 27, 2023) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) announced it
Read MoreDecember 14, 2022
LOVE PHARMA SELLS MICRODOZ, INCREASES FOCUS ON BIOTECHNOLOGY
VANCOUVER, BC, CANADA (December 14th, 2022) – LOVE Pharma Co. (“LOVE” and or “The Company”)(CSE: LUV) (FSE: G1Q0), the Company
Read MoreNovember 2, 2022
LOVE PHARMA INVESTEE, STARTON THERAPEUTICS, STRENGTHENS BOARD WITH NEW MEMBER (RE-RELEASE)
Please see the previously announced news from Starton Therapeutics Inc. VANCOUVER, BC, CANADA (November 2nd, 2022) – LOVE Pharma Co.
Read MoreOctober 20, 2022
NALTREXONE DEMONSTRATES PROMISING LONG COVID APPLICATION
Naltrexone primarily used to treat alcohol and or opioid has now shown promise in treating Long COVID at low doses1
Read MoreOctober 19, 2022
Love Pharma Closes Acquisition of Doc Hygiene
VANCOUVER, BC, CANADA (October 19th, 2022) – LOVE Pharma Co. (“LOVE” or the “Company”)(CSE: LUV) (FSE: G1Q0), is pleased to
Read More